Form 4: Director Byington Increases Stake in Becton Dickinson Through Deferred Compensation Plan

Carrie L Byington, a director at Becton Dickinson & Co, acquired additional rights to common stock under the company's deferred compensation plan.

Summary

• On July 31, 2024, Carrie L Byington, a director of Becton Dickinson & Co (BDX), acquired 124 rights to common stock under the BD Deferred Compensation Plan.
• These rights convert to common stock on a one-for-one basis and are distributed following termination of service as a director or on specified dates.
• The price per share was $241.05.
• Following the transaction, Byington beneficially owns 1,291 rights to common stock, which includes rights acquired through dividend reinvestment since the last report.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a routine transaction related to director compensation, indicating confidence in the company's stock.

Positives

• The director's participation in the deferred compensation plan signals confidence in the company's future.

Future Outlook

The rights to common stock will convert on a one-for-one basis upon termination of the director's service or on specified dates.

Industry Context

Directors often participate in deferred compensation plans as part of their overall compensation package, aligning their interests with the long-term performance of the company. This is a common practice in publicly traded companies.

Comparison to Industry Standards

• Director compensation packages, including deferred compensation plans, are common across similar large-cap healthcare companies.
• Companies like Johnson & Johnson (JNJ) and Medtronic (MDT) also utilize deferred compensation as part of their executive and director compensation strategies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it reflects the director's continued investment in the company.

Key Dates